Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • gene sequencing

    regeneron headquarters

    Regeneron to acquire human genetics company 23andMe for $256m

    The agreement comes two months after 23andMe filed for bankruptcy protection

    - PMLiVE

    How whole genome sequencing is revolutionising the rare disease patient experience

    In this white paper, we discuss how whole genome sequencing (WGS) projects and the data sets they produce are paving the way for developments in research, diagnosis, and early interventions...

    IGNIFI

    How to Simplify Genetics & Raise Awareness Around Orphan Diseases

    Dr. Gail Ouellette, President and Scientific Director of Regroupement Québécois des Maladies Orphelines (RQMO)/Quebec Coalition of Orphan Diseases and Creator of the “Genetics Simply" website, shares her thoughts on the...

    Impetus Digital

    Leaders in Pharma: Danielle Portnik

    In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Danielle Portnik. She is currently the Regional Business Director for International with Ambry Genetics.

    Impetus Digital

    Empowered patients: shaking the foundations of healthcare

    Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...

    Blue Latitude Health

    - PMLiVE

    Genetic counsellors: the new healthcare influencers?

    Blue Latitude Health explores the relationship between physicians and genetic counsellors, and the impact this has on turning precision medicine into a reality for oncology patients.

    Blue Latitude Health

    Mastering the precision medicine opportunity

    The rise of precision medicine will transform the pharma business model, challenging the way we commercialise therapies. BLH Senior Consultant and precision medicine expert David Cooney, reveals how you can...

    Blue Latitude Health

    Training the next generation of biotech leaders

    Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy,...

    Blue Latitude Health

    Microsoft brings machine learning to genetics collaboration

    Will work with Adaptive Biotechnologies on the human immune system

    Perspective on biotech leaders

    In the latest issue of Perspective magazine, seven industry trailblazers reveal the trends, challenges and opportunities they anticipate in the biotech sector, from empowering patients to deciphering big data.

    Blue Latitude Health

    How do you define a biotech company?

    In the coming weeks we will be releasing a report that looks in detail at the commercial challenges and opportunities that a modern day biotech company faces. But before then,...

    Blue Latitude Health

    Perspective on biotech

    In this supplementary issue of Perspective, we reveal the emerging technologies taking the biotech world by storm and ask if the definition of a biotech organisation needs updating.

    Blue Latitude Health

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links